We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,318.00
Bid: 1,318.50
Ask: 1,319.50
Change: 35.50 (2.77%)
Spread: 1.00 (0.076%)
Open: 1,296.00
High: 1,321.00
Low: 1,296.00
Prev. Close: 1,282.50
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Jul 2022 14:20

RNS Number : 2217S
Persimmon PLC
12 July 2022
 

12 July 2022

Persimmon Plc (the "Company")

Director/PDMR Shareholding

Jason Windsor commenced his role as Chief Financial Officer of the Company on 11 July 2022.

As reported in Persimmon's Directors' Remuneration Report for the year ended 31 December 2021, in line with usual practice the Remuneration Committee agreed that, in recognition of Jason's forfeiture of remuneration on leaving his former employer, he would be granted buy-out awards. As previously disclosed these have been calculated to match and not exceed the value forfeited. Information in relation to the principles applied in agreeing the buy-out awards is included in that Directors' Remuneration Report. In line with the vesting schedule of the forfeited awards, certain of the buy-out awards vested immediately. Half of Jason's forfeited annual bonus for 2021 was satisfied by the grant of a buy-out award as set out below. The remaining 50% of that forfeited bonus was paid in cash, but with half of that cash amount (net of income tax and national insurance) to be used to purchase 6,191 shares in Persimmon on 11 July 2022.

The buy-out awards granted in shares on 11 July 2022 are summarised below.

Forfeited remuneration

Number of Persimmon shares subject to the buy-out award

Vesting date of buy-out award

Annual bonus for 2021

23,900 (reflecting 50% of the forfeited bonus)

March 2025

2019 Deferred Bonus

2,530

11 July 2022

2020 Deferred Bonus

18,569

In respect of 9,285 Persimmon shares, 11 July 2022

In respect of 9,284 Persimmon shares, 23 March 2023

2021 Deferred Bonus

23,829

In respect of 7,943 Persimmon shares, 11 July 2022

In respect of 7,943 Persimmon shares, 25 March 2023

In respect of 7,943 Persimmon shares, 25 March 2024

2019 Restricted Stock

17,296

11 July 2022

2020 LTIP

96,449

23 March 2023 (followed by a two year holding period)*

2021 LTIP

26,808

25 March 2024 (followed by a two year holding period)*

\* The vesting of these awards is subject to the satisfaction of the performance conditions applying to the forfeited awards.

Further details of the buy-out awards granted, shares acquired pursuant to the vesting of those buy-out awards that vested immediately, shares sold to cover tax liabilities in connection with the vesting of the awards that vested immediately, and shares purchased with the net of income tax and national insurance bonus are set out below.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jason Windsor

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer

a)

Name

Persimmon Plc

b)

LEI code

213800XI72Y57UWN6F31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1 - Grant of buy-out awards over Persimmon shares

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

Nature of the transaction

Grant of awards over Persimmon shares in respect of remuneration forfeited on leaving previous employer.

c)

Price(s) and volume(s)

Award

Price

Volume

Award granted in respect of 2021 annual bonus

Nil

23,900

Award granted in respect of 2019 deferred bonus

Nil

2,530

Award granted in respect of 2020 deferred bonus

Nil

18,569

Award granted in respect of 2021 deferred bonus

Nil

23,829

Award granted in respect of 2019 restricted stock

Nil

17,296

Award granted in respect of 2020 LTIP

Nil

96,449

Award granted in respect of 2021 LTIP

Nil

26,808

d)

Aggregated information

- Aggregated volume

- Price

 

209,381

Nil

e)

Date of the transaction

11 July 2022

f)

Place of the transaction

Outside a trading venue

 

Transaction 2 - acquisition of Persimmon shares pursuant to the partial vesting of buy-out awards

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

Nature of the transaction

Acquisition of Persimmon shares following the partial vesting of buy-out awards.

c)

Price(s) and volume(s)

 

Price

Volume

Nil

37,054

d)

Aggregated information

- Aggregated volume

- Price

 

N/A Single transaction

N/A Single transaction

e)

Date of the transaction

11 July 2022

f)

Place of the transaction

Outside a trading venue

Transaction 3 - Sale of Persimmon shares to settle tax liability

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

Nature of the transaction

Sale of shares to settle tax liability on vesting of awards.

c)

Price(s) and volume(s)

Price

Volume

£17.62958

17,936

d)

Aggregated information

- Aggregated volume

- Price

 

N/A Single transaction

N/A Single transaction

e)

Date of the transaction

11 July 2022 

f)

Place of the transaction

London Stock Exchange (XLON); Main Market

 

Transaction 4 - Acquisition of Persimmon shares

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

Nature of the transaction

Acquisition of Persimmon shares

c)

Price(s) and volume(s)

Price

Volume

£17.62958

6,191

d)

Aggregated information

- Aggregated volume

- Price

 

N/A Single transaction

N/A Single transaction

e)

Date of the transaction

11 July 2022 

f)

Place of the transaction

London Stock Exchange (XLON); Main Market

 

Tracy Davison

Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADXAFFPAEFA
Date   Source Headline
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:12 pmRNSTotal Voting Rights
22nd Sep 20223:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.